Success Metrics

Clinical Success Rate

93.9%

Based on 46 completed trials

Completion Rate

94%(46/49)

Active Trials

2(4%)

Results Posted

15%(7 trials)

Terminated

3(5%)

Phase Distribution

Ph phase_2

18%

Ph phase_4

16%

Ph phase_3

33%

Ph phase_1

19%

Ph not_applicable

11%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution55 total trials

Phase 1Safety & dosage

11(20.0%)

Phase 2Efficacy & side effects

10(18.2%)

Phase 3Large-scale testing

19(34.5%)

Phase 4Post-market surveillance

9(16.4%)

N/ANon-phased studies

6(10.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.2%

46 of 51 finished

Non-Completion Rate

9.8%

5 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(46)

Terminated(5)

Other(4)

Detailed Status

Completed46

unknown4

Terminated3

Recruiting2

Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

93.9%

Most Advanced

Phase 4

Trials by Phase

Phase 111 (20.0%)

Phase 210 (18.2%)

Phase 319 (34.5%)

Phase 49 (16.4%)

N/A6 (10.9%)

Trials by Status

recruiting24%

withdrawn24%

unknown47%

terminated35%

completed4681%

Recent Activity

2 active trials

Showing 5 of 57

completedphase_4

Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory Pathway

NCT02425774

recruitingphase_4

Clinical Trials (57)

Showing 20 of 57 trialsScroll for more

NCT02425774Phase 4

Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory Pathway

Completed

NCT05455359Phase 4

Gastrointestinal Dysmotility on Aspiration Risk

Recruiting

NCT06883175Not Applicable

Evolution of the Chicago Classification: Bridging Physiology and Mechanics

Recruiting

NCT02510976Phase 4

Prucalopride Versus Placebo in Gastroparesis

Terminated

NCT04759833Phase 3

A Study of Prucalopride For Functional Constipation in Children and Teenagers

Terminated

NCT05496179Phase 1

The Effect of Prucalopride on Gastric Emptying in Intensive Care Unit Patients

Completed

NCT05726097Phase 3

Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure

Completed

NCT05220228Not Applicable

Prucalopride and Cognition in Recovered Depression

Completed

NCT03572790Not Applicable

Effects of Seven Day Prucalopride Administration in Healthy Volunteers

Completed

NCT05377619Phase 1

Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial

Completed

NCT04429802Not Applicable

The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity

Completed

NCT02947269Phase 3

Prucalopride in Postoperative Ileus

Completed

NCT05001763Phase 2

Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy

Unknown

NCT01707667Phase 4

Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity

Completed

NCT01424228Phase 4

Evaluation of Long-term Prucalopride Treatment With Chronic Constipation in Subjects Aged ≥ 18 Years

Completed

NCT01117051Phase 3

Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation

Terminated

NCT01330381Phase 3

Prucalopride in Pediatric Subjects With Functional Constipation

Completed

NCT01147926Phase 3

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Completed

NCT02047045Not Applicable

Effect Comparison of Electro-acupuncture and Prucalopride for Severe Chronic Constipation: a Randomized Controlled Trial

Completed

NCT02031081Phase 2

Prucalopride Versus Placebo in Gastroparesis

Completed

Drug Details

Intervention Type: DRUG
Total Trials: 57